Source - LSE Regulatory
RNS Number : 9127Z
Zotefoams PLC
26 May 2021
 

Zotefoams plc

('the Company')

 

Result of the 2021 Annual General Meeting

 

26 May 2021 - The 2021 Annual General Meeting of Zotefoams plc was held at the offices of Zotefoams plc, 675 Mitcham Road, Croydon CR9 3AL on 26 May 2021.

 

Proxy votes were received from shareholders in respect of 30,843,830  ordinary shares amounting to 63.4 % of the issued share capital. The total number of ordinary shares in issue in relation to the AGM is 48,621,234.

 

All resolutions put to the meeting were passed. Resolutions 1 to 13 inclusive were passed as ordinary resolutions on a show of hands and resolutions 14 to 18 inclusive were passed as special resolutions on a poll. The results of the poll vote and the proxy votes cast in respect of the resolutions received prior to the meeting were as follows:

 

Resolution

For

Against

Discretion

Votes Withheld

1.

To receive the Annual Report of the Company for the year ended 31 December 2020

30,834,790

0

9,040

250

2.

To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2020 set out on pages 70 to 80 of the Annual Report.

30,514,306

320,484

9,040

250

3.

To declare a final dividend for the year ended 31 December 2020 of 4.27 pence per ordinary share, such dividend to be payable on 1 June 2021 to shareholders on the register of members of the Company at the close of business on 7 May 2021.

30,834,790

0

9,040

250

4.

To re-elect S P Good as a Director.

29,408,438

1,400,352

9,040

26,250

5.

To elect D B Stirling as a Director.

30,808,790

0

9,040

26,250

6. 

To re-elect G C McGrath as a Director.

30,808,190

600

9,040

26,250

7. 

To re-elect J D Carling as a Director.

30,808,790

0

9,040

26,250

8. 

To re-elect A M Fielding as a Director.

30,406,794

401,396

9,040

26,850

9. 

To re-elect D G Robertson as a Director.

30,808,790

0

9,040

26,250

10.

To re-elect C A Wall as a Director.

30,808,190

0

9,040

26,850

11.

To re-appoint PKF Littlejohn LLP as Auditor of the Company.

30,688,234

556

9,040

146,250

12.

To authorise the Audit Committee to determine the Auditor's remuneration.

30,808,234

556

9,040

26,250

13.

To authorise the Directors to allot shares.

30,256,568

172,430

382,315

32,767

14.

To authorise the Directors to allot equity securities for cash.

30,334,534

120,000

385,315

4,231

15.

To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and refinancing) purposes only.

30,335,134

120,000

385,315

3,631

16.

To authorise market purchases of shares.

30,451,739

259

385,315

6,767

17.

That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.

29,945,857

486,058

385,315

26,850

18

That, with effect from the conclusion of the AGM and pursuant to Section 21(1) of the Companies Act 2006, the Articles of Association produced to the meeting, and for the purpose of identification signed by the Chair, be approved and adopted as the Articles of Association of the Company in substitution for, and to the exclusion of, the existing Articles of Association of the Company.

30,312,515

120,000

385,315

26,250

 

 

Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2021 Annual General Meeting, which is at the rear of the 2020 Annual Report and which is also available on the Company's website.

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBBGDUXGDDGBL
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Zotefoams PLC (ZTF)

-5.00p (-1.33%)
delayed 06:15AM